A Closer Look

RESEARCH GRANT AWARDS

AWARDS LIST.

Totals by Year

2020 - $630,000

2019 - $690,000

2018 - $750,000

2017 - $747,772

2016 - $720,000

2015 - $840,000

2014 - $810,000

2013 - $808,500

2012 - $720,000

2011 - $599,780

2010 - $438,000

2009 - $435,000

2008 - $619,993

2007 - $232,600

2006 - $384,551

Ryan Marker, PhD

2020

 $     30,000

Feasibility and effectiveness of an Innovative exercise program to reduce fatigue in rural cancer survivors

Breelyn Wilky, MD & Eduardo Davila, PhD

2020

 $     60,000

Toxicity and Biodistribution of CD*:MyD88 Engineered Autologous T Cells In Mouse Models of Melanoma and Fibrosarcoma

Zachary Graff, MD

2020

 $     30,000

Development of Bispecific CAR T-cells for the Prevention of Lineage Switch in KMT2A-rearranged Leukemia

Senthilnath Lakshmana Chetty, PhD

2020

 $     30,000

Combining radiation and Immunotherapy to target diffuse midline gliomas with the H3K27M mutation

Christine Towers, PhD

2020

 $     30,000

Identifying novel regulators of mitochondrial turn over

Swati G. Patel, MD, MS

2020

 $     30,000

Identification of Hereditary Cancer Syndromes through Advanced Polyps

Rebecca Schweppe, PhD

2020

 $     30,000

The role of Nuclear FAK in Thyroid Cancer

Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD

2020

 $     60,000

Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells

Matthew Tallaferro, PhD

2020

 $     30,000

Control of cell division through centrosomal RNA localization

Raphael Nemenoff, PhD & Erin Schenk, MD, PhD

2020

 $     60,000

The Tumor Microenvironment as a Critical  Regulator of Targeted Therapy in ALK Positive Lung Cancer

Paula Jedlicka, MD, PhD

2020

 $     30,000

Understanding and targeting highly metastatic EWS/FLi1-low cells in Ewing Sarcoma

Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD

2020

 $     60,000

The role of alpha-1 antitrypsin in cancer immunotherapy

Molishree Joshi, PhD

2020

 $     30,000

A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma

Diana M. Cittelly, PhD

2020

 $     30,000

Function of Ephrin B Signaling in Breast cancer brain metastasis

Maureen Lynch, Phd & Philip Owens, PhD

2020

 $     60,000

The role of exercise in breast cancer bone metastasis

Matthew Sikora, PhD

2019

 $              30,000

Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma

Isabel Schlaepfer, PhD

2019

 $              30,000

Role of fat oxidation via CPT1A in immunological response to prostate cancer

Rajeev Vibhakar, MD, PhD, MPH

2019

 $              30,000

Role of CDK7 in medulloblastoma

John Tentler, PhD

2019

 $              30,000

Cancer Research Summer Fellowship Program

Jay Hesselberth, PhD

2019

 $              30,000

Single-cell methods to measure functional heterogeneity

Mayumi Fujita, MD, PhD  & Donald Backos, PhD

2019

 $              60,000

Somatic mutations in inflammasome genes in melanoma

Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD

2019

 $              60,000

CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG

Zachary Levi Watson, PhD

2019

 $              30,000

Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer

Cem Altunbas, PhD

2019

 $              30,000

High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy

Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD

2019

 $              60,000

Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma

Carol Sartorius, PhD

2019

 $              30,000

PR-RAR downregulation of protein synthesis and cell growth in breast cancer

Heather Brechbuhl, PhD

2019

 $              30,000

Defining reversible tumor traits in the obese microenvironment

Shi-Long Lu, MD, PhD and Daniel Frank, PhD

2019

 $              60,000

Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy

Yiqun Shellman, PhD & Martin McCarter, MD

2019

 $              60,000

Targeting anti-apoptotic pathways to improve immunotherapies for melanoma

Paul Norman, PhD

2019

 $              30,000

Natural Killer cells can protect from developing leukemia

Stephen Keysar, PhD

2019

 $              30,000

Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation

Neil Box, PhD

2019

 $              30,000

Regulation of p53 in tanning

Adam Mueller, MD, PhD

2019

 $              30,000

Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer

Jill Slansky PhD

2018

 $     30,000

Functional activation of low-affinity T cells in the tumor

David Thomas, PhD and Mark Borden, PhD

2018

 $     30,000

X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy

Zhangguo Chen, PhD

2018

 $     30,000

Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy

Courtney Jones, PhD

2018

 $     30,000

Targeting relapse leukemia stem cells through inhibition of NAD synthesis

Linda Van Dyk, PhD

2018

 $     30,000

Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis

Mair E.A. Churchill, PhD

2018

 $     30,000

Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis

Nicholas Forman, MD

2018

 $     30,000

Characterization of heterogeneous tumor subpopulations in childhood ependymoma

John Tentler, PhD

2018

 $     30,000

Cancer Research Summer Fellowship Program

Nathan Dahl, MD

2018

 $     30,000

Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma

Jennifer DeLuca, PhD

2018

 $     30,000

Targeting Kinetochore Dysfunction in Cancer Cells

Martin McCarter, MD

2018

 $     30,000

Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function

Benjamin Bitler, PhD

2018

 $     30,000

Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance

Adwitiya Kar, PhD and Margaret Wierman, MD

2018

 $     30,000

Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma

Christopher Lieu, MD and Todd Pitts, MD

2018

 $     60,000

Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer

Jessica Lake, MD, MPH

2018

 $     30,000

IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas

David Ryan Ormond MD

2018

 $     30,000

Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety

Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD

2018

 $     60,000

Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma

Jennifer Hintzsche, PhD

2018

 $     30,000

Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer

Scott Cramer, PhD and James Costello, PhD

2018

 $     60,000

Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7

Maria Jose Contreras, PhD

2018

 $     30,000

Mechanisms of TDM1/radiation-induced toxicity in brain metastases

Raul M. Torres, PhD

2018

 $     30,000

Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid

Rebecca Schweppe, PhD

2018

 $     30,000

Cooperative Src and MAP Kinase Signaling in Thyroid Cancer

Eric Clambey, PhD

2017

30,000

High-dimensional analysis of effector T cell mechanisms in lung cancer

Jung-Jae Lee, PhD

2017

29,835

Storable, Thermally Activated, Self-Illuminating Nanoparticles Optical Imaging of Cancer

David Bentley, PhD

2017

30,000

Deregulation of mRNA 3′ end formation in breast cancer

Jing H. Wang, MD, PhD

2017

30,000

Elucidate novel mechanisms of chemotherapy agent-treated lymphomas to activate immune responses

Britta Jacobsen, PhD

2017

30,000

Examining the role of c-Kit in metastasis of Invasive Lobular Breast Cancer

Traci R. Lyons, PhD and      Beth Taburini, PhD

2017

60,000

Evaluating the role of pro-lymphangiogenic factor Sem7a in dampening anti-tumor immunity

Matthew J. Sikora, PhD

2017

30,000

Exploiting apoptotic vulnerability in anti-estrogen response and resistance in invasive lobular carcinoma

Kasey Couts, PhD

2017

30,000

Improving targeted therapy in melanomas with BRAF fusions

James DeGregori, PhD

2017

30,000

Understanding how smoking alters selection for common oncogenic mutations in the genesis of lung cancer

Sana Karam, MD, PhD

2017

30,000

Enhancing the Effects of Immune Checkpoint Blockade with Radiation Therapy in Head and Neck Cancer

Rebecca Schweppe, PhD

2017

30,000

Targeting FAK and Src in Thyroid Cancer

John Tentler, PhD

2017

30,000

Cancer Research Summer Fellowship Program

Daniel V. LaBarbera, PhD and Wells A. Messersmith, MD

2017

60,000

Patient Derived Tumor Organoids for Personalized and Targeted Colorectal Cancer Therapeutics

Todd Hankinson, MD, MBA

2017

27,976

Comparison of Adult Adamantinomatous Craniopharyngioma Gene Expression with Known Pediatric Gene Expression

Changwei Liu, PhD

2017

30,000

Validating USP35 as an anticancer drug target

Hyunmin Kim, PhD

2017

30,000

Systematic Alternative Splicing Analysis for Trancriptomic Misregulation in Cancer

Darinee Tippimanchai, PhD

2017

30,000

Targeting IL17 in Kras mutant lung cancer

Jenna Sopfe, MD

2017

29,961

Evaluation of Malgylcemia via Continuous Glucose monitoring in the Pediatric Hematopoietic Stem Cell Transplant Population

Dan Theodorescu, MD, PhD

2017

30,000

Whole genome knockout screening to identify novel TERT regulators with prognostic relevance in bladder cancer patients

James Costello, PhD

2017

30,000

Measuring chromosome-conformation abnormalities within a single cancer cell

MAKE A DIFFERENCE!

Volunteer, Join, and Participate today